Literature DB >> 12663811

The processing of eIF4GI by human rhinovirus type 2 2A(pro): relationship to self-cleavage and role of zinc.

Walter Glaser1, Andrea Triendl, Tim Skern.   

Abstract

The 2A proteinase (2A(pro)) of human rhinoviruses (HRVs) is a cysteine protease containing a structurally important zinc ion. In the viral polyprotein, the enzyme cleaves between the C terminus of VP1 and its own N terminus. 2A(pro) also processes the two isoforms of the cellular protein, eukaryotic initiation factor 4G (eIF4G). We have shown that mature HRV2 2A(pro), when translated in vitro in rabbit reticulocyte lysates, efficiently cleaves eIF4GI, although the enzyme was not immediately active upon synthesis. Here, we examine the relationship between self-processing and eIF4GI cleavage. The onset of both reactions first occurred at least 10 min after initiation of protein synthesis. Furthermore, when self-processing was prevented by a specific mutation between VP1 and 2A(pro), the VP1-2A(pro) precursor was essentially unable to cleave eIF4GI, implying that self-processing is a prerequisite for eIF4GI cleavage. 2A(pro) synthesized in the presence of a potent zinc chelator is inactive; however, upon addition of excess zinc, HRV2 2A(pro) rapidly gained activity. Finally, the presence of the zinc chelator in the culture medium can protect HeLa cells from HRV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663811      PMCID: PMC152162          DOI: 10.1128/jvi.77.8.5021-5025.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Extremely efficient cleavage of eIF4G by picornaviral proteinases L and 2A in vitro.

Authors:  W Glaser; T Skern
Journal:  FEBS Lett       Date:  2000-09-01       Impact factor: 4.124

2.  Recognition of eukaryotic initiation factor 4G isoforms by picornaviral proteinases.

Authors:  Nicole Foeger; Walter Glaser; Tim Skern
Journal:  J Biol Chem       Date:  2002-09-11       Impact factor: 5.157

3.  Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides.

Authors:  B D Korant; B E Butterworth
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

4.  Multiple eIF4GI-specific protease activities present in uninfected and poliovirus-infected cells.

Authors:  Miguel Zamora; Wilfred E Marissen; Richard E Lloyd
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Foot-and-mouth disease virus leader proteinase: involvement of C-terminal residues in self-processing and cleavage of eIF4GI.

Authors:  W Glaser; R Cencic; T Skern
Journal:  J Biol Chem       Date:  2001-07-17       Impact factor: 5.157

6.  A second protease of foot-and-mouth disease virus.

Authors:  K Strebel; E Beck
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

7.  Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing.

Authors:  R E Lloyd; M J Grubman; E Ehrenfeld
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

8.  Structure of alpha-chymotrypsin refined at 1.68 A resolution.

Authors:  H Tsukada; D M Blow
Journal:  J Mol Biol       Date:  1985-08-20       Impact factor: 5.469

9.  Substrate requirements of a human rhinoviral 2A proteinase.

Authors:  T Skern; W Sommergruber; H Auer; P Volkmann; M Zorn; H D Liebig; F Fessl; D Blaas; E Kuechler
Journal:  Virology       Date:  1991-03       Impact factor: 3.616

10.  Direct cleavage of elF4G by poliovirus 2A protease is inefficient in vitro.

Authors:  M L Bovee; B J Lamphear; R E Rhoads; R E Lloyd
Journal:  Virology       Date:  1998-06-05       Impact factor: 3.616

View more
  9 in total

1.  Host and viral translational mechanisms during cricket paralysis virus infection.

Authors:  Julianne L Garrey; Yun-Young Lee; Hilda H T Au; Martin Bushell; Eric Jan
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

2.  Inhibition of polyprotein processing and RNA replication of human rhinovirus by pyrrolidine dithiocarbamate involves metal ions.

Authors:  B M Krenn; B Holzer; E Gaudernak; A Triendl; F J van Kuppeveld; J Seipelt
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  The correlation between prognosis of HCMV infection and zinc in mature women.

Authors:  Dan Li; Liangzhen Wen; Hui Yuan; Nan Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

4.  Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells.

Authors:  Juliet M Morrison; Vincent R Racaniello
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

5.  Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome.

Authors:  N Kaushik; D Fear; S C M Richards; C R McDermott; E F Nuwaysir; P Kellam; T J Harrison; R J Wilkinson; D A J Tyrrell; S T Holgate; J R Kerr
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

6.  An antiviral peptide inhibitor that is active against picornavirus 2A proteinases but not cellular caspases.

Authors:  Luiza Deszcz; Regina Cencic; Carla Sousa; Ernst Kuechler; Tim Skern
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  Structure and dynamics of coxsackievirus B4 2A proteinase, an enyzme involved in the etiology of heart disease.

Authors:  Nicola J Baxter; Andreas Roetzer; Hans-Dieter Liebig; Svetlana E Sedelnikova; Andrea M Hounslow; Tim Skern; Jonathan P Waltho
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 8.  Structures and Corresponding Functions of Five Types of Picornaviral 2A Proteins.

Authors:  Xiaoyao Yang; Anchun Cheng; Mingshu Wang; Renyong Jia; Kunfeng Sun; Kangcheng Pan; Qiao Yang; Ying Wu; Dekang Zhu; Shun Chen; Mafeng Liu; Xin-Xin Zhao; Xiaoyue Chen
Journal:  Front Microbiol       Date:  2017-07-21       Impact factor: 5.640

9.  NMR analysis of the interaction of picornaviral proteinases Lb and 2A with their substrate eukaryotic initiation factor 4GII.

Authors:  Martina Aumayr; Sofiya Fedosyuk; Katharina Ruzicska; Carla Sousa-Blin; Georg Kontaxis; Tim Skern
Journal:  Protein Sci       Date:  2015-10-04       Impact factor: 6.725

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.